Metformin vs Raltegravir Potassium
Metformin vs Raltegravir Potassium: Overview
This comparison examines the pharmacological differences between Metformin and Raltegravir Potassium.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Metformin β 4-9 hours.
Chemical Properties
Molecular Formula: Metformin β C4H11N5.
Molecular Weight: Metformin β 129.1640 g/mol.
Type: Metformin β Small molecule; Raltegravir Potassium β Small molecule.